"Effect of Ibuprofen on Acute Inflammatory Response After One-Stage Periodontal Therapy"
Efficacy Of Ibuprofen In Reducing Acute Inflammatory Response Following One Stage Non- Surgical Periodontal Therapy (A Randomized Clinical Trial )
University of Baghdad
30 participants
Dec 1, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this ( Clinical Trial ) is to evaluate the efficacy of Ibuprofen in reducing acute inflammatory response (hs-CRP, ProCT, IL-6) after one hour and one week following one stage non surgical periodontal therapy. The main question it aims to answer is: "Does Ibuprofen effectively reduce the acute inflammatory response ( hs-CRP, ProCT, IL-6) following one-stage non-surgical periodontal therapy?"
Eligibility
Inclusion Criteria6
- systemically healthy patients.
- having a minimum of 20 teeth.
- Generalized unstable periodontitis.
- Pocket depth \[≥ 4 mm\].
- All included participants should be adults aged more than 18 years .
- smokers and non smokers
Exclusion Criteria12
- Allergy or hypersensitivity to Ibuprofen or other NSAIDs.
- current systemic anti-inflammatory or antibiotic therapy (\<3 months).
- peptic ulcer disease.
- recent periodontal therapy (\<3 months).
- Asthma.
- Renal impairment .
- Hepatic impairment.
- Severe cardiac disease (heart failure, hypertension (.
- Bleeding disorders (e.g., hemophilia) or patients taking anticoagulants .
- Any participant who had known or suspected high risk for tuberculosis, hepatitis B or HIV infections.
- pregnant or lactating females.
- those being unable to provide written informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Control group: After one week from baseline visit which include supragingival debridement by using ultrasonic device . sites will receive root surface debridement (RSD) using area specific (Gracey) curettes (Medesy, Italy). Without receiving Ibuprofen.
Test group: After one week from baseline visit which include supragingival debridement by using ultrasonic device . Test group will receive first dose of Ibuprofen (400 mg) administer one hour before root surface debridement and the subsequent doses will be taken 3 times daily for a duration of 3 days after RSD.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07459049